SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-011492
Filing Date
2022-02-03
Accepted
2022-02-03 19:02:55
Documents
1
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm225348d3_4.html 4  
1 OWNERSHIP DOCUMENT tm225348d3_4.xml 4 6608
  Complete submission text file 0001104659-22-011492.txt   8138
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703
Business Address
Hollander David (Reporting) CIK: 0001793796 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 22590259